Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

M. Voysey, Sue Ann Costa Clemens, S. Madhi, L. Weckx, P. Folegatti, P. Aley, B. Angus, V. Baillie, S. Barnabas, Q. Bhorat, S. Bibi, Carmen Briner, P. Cicconi, E. Clutterbuck, A. Collins, C. Cutland, T. Darton, K. Dheda, C. Dold#, C. Duncan, K. Emary, K. Ewer, A. Flaxman, L. Fairlie, S. Faust, S. Feng, D. Ferreira, A. Finn, E. Galiza, A. Goodman, C. Green, C. Green, M. Greenland, C. Hill, H. Hill, I. Hirsch, A. Izu, D. Jenkin, Carina C D Joe, S. Kerridge, A. Koen, G. Kwatra, R. Lazarus, V. Libri, P. Lillie, N. Marchevsky, Richard P. Marshall, A. V. Mendes, E. P. Milan, A. Minassian, A. McGregor, Y. Mujadidi, Anusha Nana, Sherman D. Padayachee, D. Phillips, Ana Pittella, E. Plested, Katrina M Pollock, M. Ramasamy, A. Ritchie, H. Robinson, A. Schwarzbold, Andrew Smith, R. Song, M. Snape, E. Sprinz, R. Sutherland, E. Thomson, M. E. Török, M. Toshner, D. Turner, J. Vekemans, T. Villafana, T. White, Christopher J Williams, A. D. Douglas, A. Hill, T. Lambe, S. Gilbert, A. Pollard, Marites Kushala W.M. Jeremy Matthew Kirsty James P. Gbadeb Aban Abeyskera Aboagye Adam Adams Adamson Adewatan, M. Aban, K. Abeyskera, Jeremy Aboagye, M. Adam, Kirsty Adams, J. Adamson, Gbadebo Adewatan, Syed Adlou, K. Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, A. Alcock, Aabidah Ali, E. Allen, L. Allen, Felipe B. Alvernaz, F. Amorim, C. S. Andrade, Foteini Andritsou, R. Anslow, Edward H Arbe-Barnes, M. Ariaans, Beatriz Arns, Laiana Arruda, L. Assad, P. Azi, L. Azi, G. Babbage, C. Bailey, K. Baker, M. Baker, Natalie Baker, P. Baker, Ioana Baleanu, Daniel Bandeira, A. Bara, Marcella A.S. Barbosa, Debbie Barker, G. Barlow, E. Barnes, A. Barr, J. Barrett, Jessica Barrett, Kelly Barrett, L. Bates, Alexander Batten, Kirsten Beadon, Emily R Beales, R. Beckley, S. Belij-Rammerstorfer, Jonathan Bell, D. Bellamy, Sue Belton, A. Berg, L. Bermejo, E. Berrie, L. Berry, Daniella Berzenyi, A. Beveridge, K. Bewley, Inderjeet Bharaj, Sutika Bhikha, A. Bhorat, Zaheda E. Bhorat, E. Bijker, S. Birch, Gurpreet Birch, Katherine Birchall, Adam Bird, Olivia Bird, K. Bisnauthsing, M. Bittaye, L. Blackwell, Rachel Blacow, Heather Bletchly, C. Blundell, Susannah R. Blundell, P. Bodalia, Emma Bolam, E. Boland, Daan Bormans, N. Borthwick, Francesca Bowring, A. Boyd, P. Bradley, T. Brenner, Alice Bridges-Webb, Phillip J Brown, Claire Brown, Charlie Brown-O'Sullivan, Scott Bruce, Emily Brunt, W. Budd, Yusuf A. Bulbulia, M. Bull, J. Burbage, Aileen Burn, K. Buttigieg, Nicholas Byard, Ingrid Cabrera Puig, A. Calvert, S. Camara, M. Cao, F. Cappuccini, Rita Cardona, J. R. Cardoso, Melanie Carr, M. Carroll, A. Carson-Stevens, Y. D. M. Carvalho, Helen R. Casey, Paul Cashen, T. Castro, Lucia Carratala Castro, K. Cathie, A. Cavey, J. Cerbino-Neto, Luiz Cezar, Jim Chadwick, Chanice Chanice, D. Chapman, S. Charlton, Katerina S. Cheliotis, I. Chelysheva, Oliver Chester, Emily Chiplin, S. Chita, J. Cho, L. Cifuentes, E. Clark, M. Clark, Rachel Colin-Jones, S. Collins, H. Colton, C. Conlon, Sean Connarty, N. Coombes, C. Cooper, Rachel Cooper, L. Cornelissen, T. Corrah, C. Cosgrove, Fernanda Barroso Costa, Tony Cox, Wendy E.M. Crocker, S. Crosbie, D. Cullen, Debora R.M.F. Cunha, C. Cunningham, Fiona C. Cuthbertson, D. M. da Costa, S. F. D. da Guarda, L. P. da Silva, Antonio Carlos da Silva Moraes, B. E. Damratoski, Zsófia Dános, M. C. Dantas, M. Datoo, Chandrabali Datta, M. Davids, Sarah L. Davies, K. Davies, Hannah Davies, S. Davies, Judith Davies, E. Davis, John Davis, J. A. D. de Carvalho, Jeanne De Jager, Sergio de Jesus Jnr, Lis Moreno De Oliveira Kalid, D. Dearlove, T. Demissie, A. Desai, S. Di Marco, Claudio Di Maso, T. Dinesh, Claire Docksey, T. Dong, F. Donnellan, Tannyth Gomes Dos Santos, T. G. dos Santos, Erika Pachecho Dos Santos, N. Douglas, C. Downing, J. Drake, R. Drake-Brockman, R. Drury, J. Du Plessis, S. Dunachie, A. Duncan, N. Easom, Mandy Edwards, N. Edwards, F. Edwards, Omar M. El Muhanna, Sean Elias, Branwen Ellison-Handley, M. Elmore, M. English, A. Esmail, Yakub Moosa Essack, Mutjaba Farooq, S. Fedosyuk, S. Felle, Susie Ferguson, Carla Ferreira da Silva, Samantha M. Field, Richard Fisher, James Fletcher, Hazel Fofie, H. Fok, K. Ford, Ross Fothergill, Jamie Fowler, P. Fraiman, E. Francis, M. M. Franco, J. Frater, Marilúcia S.M. Freire, Samantha H. Fry, Sabrina Fudge, Renato Furlan Filho, J. Furze, M. Fuskova, Pablo Galian-Rubio, Harriet Garlant, Madita Gavrila, K. Gibbons, Ciaran Gilbride, H. Gill, K. Godwin, Karishma Gokani, M. Gonçalves, I. Gonzalez, J. Goodall, Jayne Goodwin, Amina Goondiwala, Katherine Gordon-Quayle, Giacomo Gorini, Alvaro Goyanna, J. Grab, Lara Gracie, Justin Green, N. Greenwood, Johann Greffrath, Marisa M. Groenewald, A. Gunawardene, Gaurav Gupta, M. Hackett, B. Hallis, M. Hamaluba, Elizabeth Hamilton, Joseph Hamlyn, D.R.H. Hammersley, A. Hanrath, Brama Hanumunthadu, Stephanie A. Harris, C. Harris, T. Harrison, D. Harrison, Tara Harris-Wright, T. C. Hart, B. Hartnell, J. Haughney, S. Hawkins, Laís Y.M. Hayano, I. Head, P. Heath, J. Henry, Macarena Hermosin Herrera, David Hettle, Cristhiane Higa, Jennifer Hill, Gina Hodges, Susanne H Hodgson, Elizea Horne, Mimi M. Hou, C. Houlihan, Elizabeth Howe, Nicola J. Howell, Jonathan Humphreys, H. Humphries, K. Hurley, C. Huson, C. Hyams, A. Hyder-Wright, S. Ikram, Alka Ishwarbhai, Poppy Iveson, V. Iyer, F. Jackson, Susan A. Jackson, S. Jaumdally, H. Jeffers, N. Jesudason, Carina Jones, C. Jones, K. Jones, E. Jones, M. R. Jorge, A. Joshi, E. A. Júnior, Reshma Kailath, Faeeza Kana, Arnab Kar, Konstantinos Karampatsas, Mwila Kasanyinga, L. Kay, J. Keen, Johanna K Kellett Wright, E. Kelly, D. Kelly, Dearbhla M. Kelly, Sarah Kelly, D. Kerr, Liaquat Khan, Baktash Khozoee, Ankush Khurana, S. Kidd, Annabel Killen, J. Kinch, Patrick Kinch, L. King, T. King, Lucy Kingham, P. Klenerman, Diana Kluczna, Francesca Knapper, J. Knight, Daniel Knott, Stanislava Koleva, P. Lages, Matilda Lang, Gail Lang, Colin W. Larkworthy, J. P. Larwood, R. Law, A. Lawrie, E. Lazarus, A. Leach, E. Lees, Alice Lelliott, N. Lemm, Á. Lessa, Stephanie Leung, Yuanyuan Li, A. Lias, K. Liatsikos, Aline Linder, S. Lipworth, Shuchang Liu, Xinxue Liu, A. Lloyd, Stephanie Lloyd, L. Loew, R. Lopez Ramon, L. Lora, K. Luz, J. C. MacDonald, G. MacGregor, Meera Madhavan, David O. Mainwaring, E. Makambwa, R. Makinson, M. Malahleha, Ross Malamatsho, Garry Mallett, N. Manning, Kushal Mansatta, Takalani Maoko, S. Marinou, Emma Marlow, G. N. Marques, Paula Marriott, Richard P. Marshall, Julia L. Marshall, Masebole Masenya, Mduduzi S. L. Masilela, S. Masters, Moncy Mathew, Hosea Matlebjane, Kedidimetse Matshidiso, O. Mazur, A. Mazzella, H. McCaughan, Joanne Mcewan, J. McGlashan, Lorna McInroy, Nicky McRobert, S. McSwiggan, Clare Megson, Savviz Mehdipour, W. Meijs, Renata Mendonça, A. Mentzer, Ana Carolina F. Mesquita, Patricia Miralhes, N. Mirtorabi, C. Mitton, Sibusiso Mnyakeni, F. Moghaddas, Kgaogelo Molapo, Mapule Moloi, M. Moore, Marni Moran, Ella Morey, R. Morgans, Susan J. Morris, S. Morris, H. Morrison, F. Morselli, Gertraud Morshead, R. Morter, L. Mottay, A. Moultrie, N. Moyo, Mushiya Mpelembue, S. Msomi, Yvonne Mugodi, E. Mukhopadhyay, J. Muller, A. Munro, Sarah Murphy, Philomena Mweu, C. Myerscough, G. Naik, Kush Naker, E. Nastouli, B. Ndlovu, E. Nikolaou, C. Njenga, H. Noal, Andrés Noé, Gabrielle Novaes, Fay L. Nugent, G. Nunes, K. O'Brien, D. O’Connor, S. Oelofse, B. Oguti, Victoria Olchawski, N. Oldfield, Marianne G. Oliveira, Catarina Oliveira, Isabelle Silva Queiroz Oliveira, Aylin Oommen-Jose, Angela Oosthuizen, P. O'Reilly, P. O'Reilly, Piper Osborne, D. Owen, L. Owen, Daniel R Owens, N. Owino, Mihaela Pacurar, Brenda V.B. Paiva, Edna M.F. Palhares, S. Palmer, Helena Parracho, K. Parsons, Dipak B. Patel, B. Patel, Faeezah Patel, Maia Patrick-Smith, R. Payne, Yanchun Peng, E. Penn, Anna Pennington, Marco Polo Peralta Álvarez, Bruno Pereira Pereira Stuchi, Ana Luiza Perez, Tanaraj Perinpanathan, J. Perring, R. Perumal, S. Petkar, Tricia Philip, J. Phillips, Mary Kgomotso Phohu, L. Pickup, Sonja Pieterse, J. Pinheiro, J. Piper, Dimitra Pipini, M. Plank, Sinéad Plant, Samuel Pollard, J. Pooley, A. Pooran, I. Poulton, C. Powers, F. Presa, D. Price, V. Price, M. Primeira, Pamela C. Proud, Samuel Provstgaard-Morys, S. Pueschel, D. Pulido, Sheena Quaid, R. Rabara, K. Radia, Durga Rajapaska, Thurkka Rajeswaran, Leonardo Ramos, Alberto San Francisco Ramos, F. Ramos Lopez, T. Rampling, Jade Rand, H. Ratcliffe, T. Rawlinson, D. Rea, Byron Rees, Mila Resuello-Dauti, Emilia Reyes Pabon, S. Rhead, Tawassal Riaz, Marivic Ricamara, Alexander Richards, A. Richter, Neil Ritchie, A. Ritchie, Alexander J. Robbins, H. Roberts, R. Robinson, S. Roche, C. Rollier, Louisa Rose, Amy L Ross Russell, Lindie Rossouw, S. Royal, Indra Rudiansyah, Kim Ryalls, C. Sabine, Stephen Saich, Jessica Sale, A. Salman, N. Salvador, Stephannie Salvador, M. Sampaio, A. D. Samson, A. Sánchez-González, Helen Sanders, K. Sanders, Erika Santos, M. S. Santos Guerra, I. Satti, J. Saunders, C. Saunders, A. Sayed, I. Schim van der Loeff, A. Schmid, Ella Schofield, G. Screaton, Samiullah Seddiqi, R. R. Segireddy, R. Senger, Sonia Serrano, Imam H Shaik, H. Sharpe, K. Sharrocks, R. Shaw, Adam Shea, Emma Sheehan, A. Shepherd, Farah Shiham, S. Silk, L. Silva-Reyes, L. B. T. Silveira, M. B. Silveira, Nisha Singh, J. Sinha, D. Skelly, Daniel C. Smith, N. Smith, Holly E. Smith, D. Smith, Catherine C. Smith, Airanuédida S. Soares, C. Solórzano, Guilherme L. Sorio, Kim Sorley, Tiffany Sosa-Rodríguez, Cinthia M.C.D.L. Souza, Bruno Solano de Freitas Souza, Alessandra R. Souza, Thamyres Souza Lopez, L. Sowole, Alexandra J. Spencer, L. Spoors, Lizzie Stafford, Imogen Stamford, R. Stein, L. Stockdale, Lisa V. Stockwell, L. Strickland, A. Stuart, A. Sturdy, N. Sutton, Anna Szigeti, A. Tahiri-Alaoui, R. Tanner, Carol Taoushanis, A. Tarr, R. Tarrant, Keja Taylor, U. Taylor, I. Taylor, Justin Taylor, Rebecca te Water Naude, K. Templeton, Y. Themistocleous, Andreas C. Themistocleous, Merin Thomas, K. Thomas, Tonia M. Thomas, Asha Thombrayil, J. Thompson, F. Thompson, A. Thompson, A. Thompson, Kevin Thompson, V. Thornton-Jones, Larissa H.S. Thotusi, P. Tighe, Lygia Accioly Tinoco, G. Tiongson, Bonolo Tladinyane, M. Tomasicchio, Adriana Tomic, S. Tonks, J. Towner, N. Tran, J. Tree, Gerry Trillana, Charlotte Trinham, Rose Trivett, Adam Truby, Betty Lebogang Tsheko, Philippa Tubb, Aadil Turabi, R. Turner, Cheryl Turner, N. Turner, Bhavya Tyagi, Marta Ulaszewska, B. Underwood, Samual van Eck, R. Varughese, Dennis Verbart, M. Verheul, Iason Vichos, T. Vieira, G. Walker, L. Walker, M. Wand, T. Wardell, G. Warimwe, S. Warren, B. Watkins, Marion E E Watson, E. Watson, Stewart Webb, Angela Webster, J. Welch, Z. Wellbelove, J. Wells, Alison J. West, B. White, Caroline White, Rachel White, Paul Williams, Rachel L. Williams, Silvia Willingham, R. Winslow, Danielle Woods, Mark Woodyer, A. Worth, D. Wright, Marzena Wroblewska, Andy Yao, Y. T. N. Yim, M. Zambrano, R. Zimmer, Dalila Zizi, Peter Zuidewind

The Lancet, 2021

Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4–12 weeks. The planned roll-out in the UK will involve vaccinating people in high-risk categories with their first dose immediately, and delivering the second dose 12 weeks later. Here, we provide both a further prespecified pooled analysis of trials of ChAdOx1 nCoV-19 and exploratory analyses of the impact on immunogenicity and efficacy of extending the interval between priming and booster doses. In addition, we show the immunogenicity and protection afforded by the first dose, before a booster dose has been offered. Methods We present data from three single-blind randomised controlled trials—one phase 1/2 study in the UK (COV001), one phase 2/3 study in the UK (COV002), and a phase 3 study in Brazil (COV003)—and one double-blind phase 1/2 study in South Africa (COV005). As previously described, individuals 18 years and older were randomly assigned 1:1 to receive two standard doses of ChAdOx1 nCoV-19 (5 × 1010 viral particles) or a control vaccine or saline placebo. In the UK trial, a subset of participants received a lower dose (2·2 × 1010 viral particles) of the ChAdOx1 nCoV-19 for the first dose. The primary outcome was virologically confirmed symptomatic COVID-19 disease, defined as a nucleic acid amplification test (NAAT)-positive swab combined with at least one qualifying symptom (fever ≥37·8°C, cough, shortness of breath, or anosmia or ageusia) more than 14 days after the second dose. Secondary efficacy analyses included cases occuring at least 22 days after the first dose. Antibody responses measured by immunoassay and by pseudovirus neutralisation were exploratory outcomes. All cases of COVID-19 with a NAAT-positive swab were adjudicated for inclusion in the analysis by a masked independent endpoint review committee. The primary analysis included all participants who were SARS-CoV-2 N protein seronegative at baseline, had had at least 14 days of follow-up after the second dose, and had no evidence of previous SARS-CoV-2 infection from NAAT swabs. Safety was assessed in all participants who received at least one dose. The four trials are registered at ISRCTN89951424 (COV003) and ClinicalTrials.gov, NCT04324606 (COV001), NCT04400838 (COV002), and NCT04444674 (COV005). Findings Between April 23 and Dec 6, 2020, 24 422 participants were recruited and vaccinated across the four studies, of whom 17 178 were included in the primary analysis (8597 receiving ChAdOx1 nCoV-19 and 8581 receiving control vaccine). The data cutoff for these analyses was Dec 7, 2020. 332 NAAT-positive infections met the primary endpoint of symptomatic infection more than 14 days after the second dose. Overall vaccine efficacy more than 14 days after the second dose was 66·7% (95% CI 57·4–74·0), with 84 (1·0%) cases in the 8597 participants in the ChAdOx1 nCoV-19 group and 248 (2·9%) in the 8581 participants in the control group. There were no hospital admissions for COVID-19 in the ChAdOx1 nCoV-19 group after the initial 21-day exclusion period, and 15 in the control group. 108 (0·9%) of 12 282 participants in the ChAdOx1 nCoV-19 group and 127 (1·1%) of 11 962 participants in the control group had serious adverse events. There were seven deaths considered unrelated to vaccination (two in the ChAdOx1 nCov-19 group and five in the control group), including one COVID-19-related death in one participant in the control group. Exploratory analyses showed that vaccine efficacy after a single standard dose of vaccine from day 22 to day 90 after vaccination was 76·0% (59·3–85·9). Our modelling analysis indicated that protection did not wane during this initial 3-month period. Similarly, antibody levels were maintained during this period with minimal waning by day 90 (geometric mean ratio [GMR] 0·66 [95% CI 0·59–0·74]). In the participants who received two standard doses, after the second dose, efficacy was higher in those with a longer prime-boost interval (vaccine efficacy 81·3% [95% CI 60·3–91·2] at ≥12 weeks) than in those with a short interval (vaccine efficacy 55·1% [33·0–69·9] at <6 weeks). These observations are supported by immunogenicity data that showed binding antibody responses more than two-fold higher after an interval of 12 or more weeks compared with an interval of less than 6 weeks in those who were aged 18–55 years (GMR 2·32 [2·01–2·68]). Interpretation The results of this primary analysis of two doses of ChAdOx1 nCoV-19 were consistent with those seen in the interim analysis of the trials and confirm that the vaccine is efficacious, with results varying by dose interval in exploratory analyses. A 3-month dose interval might have advantages over a programme with a short dose interval for roll-out of a pandemic vaccine to protect the largest number of individuals in the population as early as possible when supplies are scarce, while also improving protection after receiving a second dose. Funding UK Research and Innovation, National Institutes of Health Research (NIHR), The Coalition for Epidemic Preparedness Innovations, the Bill & Melinda Gates Foundation, the Lemann Foundation, Rede D’Or, the Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca.

Cited by 247 publications.

Field of study: Medicine

10.1016/S0140-6736(21)00432-3